The utility of 99m tc-dmsa and tc 99m -ec scintigraphy for early diagnosis of ifosfamide induced nephrotoxicity

Nuclear Medicine Communications

Volumn 22, Issue 12, 2001, Pages 1325-1332

  Caglar, M ^a   YariS N ^a   Akyuz, C ^a  

^a HACETTEPE UNIVERSITY   (Turkey)

Author keywords

Chemotherapy toxicity; Ifosfamide; Renal scintigraphy

Indexed keywords

BETA 2 MICROGLOBULIN; BLEOMYCIN; CISPLATIN; CYCLOPHOSPHAMIDE; CYSTEINE ETHYL ESTER TC 99M; CYTOSTATIC AGENT; GLUCOSE; IFOSFAMIDE; PHOSPHATE; PROTEIN; SUCCIMER TC 99M; VINCRISTINE;

ADOLESCENT; ARTICLE; CANCER; CANCER COMBINATION CHEMOTHERAPY; CHILD; CLINICAL ARTICLE; FEMALE; HUMAN; KIDNEY FUNCTION; KIDNEY SCINTISCANNING; KIDNEY TUBULE; MALE; NEPHROTOXICITY;

ADOLESCENT; ANTINEOPLASTIC AGENTS, ALKYLATING; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BETA 2-MICROGLOBULIN; BIOLOGICAL TRANSPORT; CHILD; CHILD, PRESCHOOL; CISPLATIN; CREATININE; CYSTEINE; FEMALE; HUMANS; IFOSFAMIDE; INFANT; KIDNEY; MALE; NEOPLASMS; ORGANOTECHNETIUM COMPOUNDS; RADIOPHARMACEUTICALS; TECHNETIUM TC 99M DIMERCAPTOSUCCINIC ACID; TISSUE DISTRIBUTION;

EID: 0035205093     PISSN: 01433636     EISSN: 14735628     Source Type: Journal    
DOI: 10.1097/00006231-200112000-00008     Document Type: Review

References (34)

1. Pratt CB. Current studies of ifosfamide for pediatric solid tumors and leukemia in United States. Semin Oncol 1992; 19: 43-50.
2. Pratt CB, Green AA, Horowitz ME, et al. Central nervous system toxicity following the treatment of pediatric patients with ifosfamide/mesna. J Clin Oncol 1986; 4: 1253-1261.
3. Skinner R, Sharkey IM, Pearson ADJ, Craft AW. Ifosfamide, mesna and nephrotoxicity in children. J Clin Oncol 1993; 11: 173-190.
4. Skinner R, Pearson A, Malcolm ARJ, et al. Assessment of chemotherapy-associated nephrotoxicity in children with cancer. Cancer Chemother Pharmacol 1991; 28: 81-92.
5. Bernard AM, Vyskocil AA, Mahieu P, Lauwerys RR. Assessment of urinary retinol-binding protein as an index of proximal tubular injury. Clin Chem 1987; 33: 775-779.
6. Piscator M. Early detection of tubular dysfunction. Kidney Int 1991; 34(Suppl.): 15-17.
7. Taylor A, Lallone R. Differential renal function in unilateral renal injury: possible effects of radiopharmaceutical choice. J Nucl Med 1985; 26: 77-80.
8. Anniga JK, Valdes-Olmos R, Kraker J, et al. Technetium 99m dimercaptosuccinic acid and ifosfamide tubular dysfunction in children with cancer. Eur J Nucl Med 1994; 21: 658-662.
9. Murase K, Tanada S, Ishine M, Yokoyama M, Hamamoto K. Methods for measuring the renal uptake of Tc-99m DMSA; a comparative study. Eur J Nucl Med 1990; 16: 725-731.
10. Schwartz GJ, Brion LP, Spitzer A. The use of plasma creatinine concentration for estimating glomerular filtration rate in infants, children and adolescents. Pediatr Clin North Am 1987; 34: 572-590.
11. Rossi R, Pleyer J, Schafers P, et al. Development of ifosfamide nephrotoxicity: prospective follow-up in 75 patients. Med Pediatr Oncol 1999; 32: 177-182.
12. Fels LM, Bokemeyer C, van Rhee J, Schmoll HJ, Stolte H. Evaluation of late nephrotoxicity in long term survivors of Hodgkin’s disease. Oncology 1996; 53: 73-78.
13. Goren MP, Wright RK, Horowitz ME, Pratt CB. Ifosfamide induced subclinical tubular nephrotoxicity despite mesna. Cancer Treat Rep 1987; 71: 127-130.
14. Frajj BM. Transferrin and albumin excretion as a measure of glomerular function. Clin Physiol Biochem 1989; 7: 296-302.
15. Junk K. Urinary enzymes and low molecular weight proteins as markers of tubular dysfunction. Kidney Int 1994; 47(Suppl.): 29-33.
16. Price RG. The role of NAG (N-acetyl-beta-D-glucoseaminidase) in the diagnosis of kidney disease including the monitoring of nephrotoxicity. Clin Nephrol 1992; 38(Suppl): 14-19.
17. Gordon I. Indications for technetium dimercaptosuccinic acid scan in children. J Urol 1987; 137: 464-467.
18. Yen TC, Chen WP, Chang SL, Liu RS, Yeh SH, Lin CY. Technetium 99m-DMSA renal SPECT in diagnosing and monitoring pediatric acute pyelonephritis. J Nucl Med 1996; 37: 1349-1353.
19. Majd M, Rushton HG. Renal cortical scintigraphy in the diagnosis of acute pyelonephritis. Semin Nucl Med 1992; 22: 98-111.
20. Crabbe DCG, Thomas DFM, Gordon AC, Irving HC, Arthur RJ, Smith SEW. Use of technetium 99m-dimercaptosuccinic acid to study patterns of renal damage associated with prenatally detected vesicoureteral reflux. J Urol 1992; 148: 1229-1231.
21. Taylor A. Quantitation of renal function with static imaging agents. Semin Nucl Med 1982; 12: 330-344.
22. Groshar D, Moskovitz B, Gorenberg M, et al. Quantitative SPECT of Tc-99m DMSA uptake of normal kidneys and in kidneys with vesicoureteral reflux: detection of unilateral kidney disease. J Nucl Med 1994; 35: 445-449.
23. Flower MA, Meller ST, Chettenden SJ, Fielding SL, Evans K, Gordon I. Absolute Tc-99m DMSA uptake in children: a study of 321 kidneys. Nucl Med Commun 1995; 16: 572-574.
24. Groshar D, Embon OM, Frenkel A, Front D. Renal function and Tc-99m dimercaptosuccinic acid uptake in single kidneys: the value of in vivo SPECT quantitation. J Nucl Med 1991; 32: 766-768.
25. Skinner R, Pearson AD, English MW, et al. Risk factors for ifosphamide nephrotoxicity. Lancet 1996; 31: 578-580.
26. Rossi R, Godde A, Kleinebrand M, et al. Unilateral nephrectomy and cisplatin as risk factors of ifosfamide-induced nephrotoxicity: analysis of 120 patients. J Clin Oncol 1994; 12: 159-165.
27. Bosch T. Nephrotoxicity and fluoride from the viewpoint of the nephrologist. Anaesthesist 1996; 45(Suppl.): 41-45.
28. Humes HD, Weinberg JM. The effect of gentamicin on antidiuretic hormone-stimulated osmotic water flow in the toad urinary bladder. J Lab Clin Med 1983; 101: 472-478.
29. Yamada M. Assessment of Tc-99m DMSA renography and uptake compared with creatinine clearance in rats with drug induced nephrotoxicity-I Gentamycin induced nephrotoxicity. Kaku Igaku 1991; 28: 339-345.
30. Yamada M. Assessment of Tc-99m DMSA renography and uptake compared with creatinine clearance in rats with drug induced nephrotoxicity-I Cisplatin induced nephrotoxicity. Kaku Igaku 1991; 28: 347-354.
31. Ham HR, Piepsz A. Estimation of glomerular filtration rate in infants and children using a single-plasma sample method. J Nucl Med 1991; 32: 1294-1297.
32. Verbruggen AM, Nosco DL, Nerom VCG, Bormans GM, Adriaens PJ, De Roo MJ. Tc-99m-L, L-ethylenedicysteine: a renal imaging agent. I. Labelling and evaluation in animals. J Nucl Med 1992; 33: 551-557.
33. Kabasakal L, Turoglu T, Onsel C, et al. Comparative continuous infusion renal clearance of Tc-99m EC, Tc-99m MAG and I-131 OIH. J Nucl Med 1995; 36: 224-228.
34. Rossi RM, Kist C, Wurster U, et al. Estimation of ifosfamide/cisplatinum-induced renal toxicity by urinary protein analysis. Pediatr Nephrol 1994; 8: 151-156.